INMD compared with PCRX: revenue, margins and what each company keeps, and the suppliers and customers both name

INMDInMode Ltd.

Mkt capRevenueRevenue

PCRXPacira BioSciences, Inc.

Mkt capRevenueRevenue

Compare

INMDInMode Ltd.

PCRXPacira BioSciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

INMD

No earnings history for INMD.

PCRX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.3%▼−9.96%×1.08

Q1 FY26±10.0%▼−4.12%×0.41

Feb 27 '26±11.0%▼−3.01%×0.27

Jan 9 '26±15.8%▼−9.57%×0.61

= impliedINMD realized, solidPCRX realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

INMDInMode Ltd.

13.32▼−0.58%· post 13.32

Mkt cap$844.6MRevenue—Revenue—

PCRXPacira BioSciences, Inc.

36.43▲+0.04%· post 36.43

ClosedNov 6 '26

Mkt cap$1.5BRevenue$177MQ3 FY26Revenue$726MFY25

Compare

ClosedNov 6 '26

INMDInMode Ltd.

PCRXPacira BioSciences, Inc.

13.32▼−0.58%post 13.32

Price

36.43▲+0.04%post 36.43

$844.6M

Mkt cap

$1.5B

—

Revenue

$177MQ3 FY26

—

Revenue

$726MFY25

INMD13.32▼−0.58%vsPCRX36.43▲+0.04%ClosedNov 6 '26